This nuclear localization strongly suggests that as a transcription factor ZEB2 exploited its regulatory activity on target genes specifically in the leading edge of the tumor, providing a commitment for the EMT process and an increased invasion ability. This evidence concerns the gene ZEB2 and neoplasm.